相关实验视频

Updated: Jan 18, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

扩大免疫疗法超越CAR T细胞:设计多种免疫细胞以向固体瘤

Tereza Andreou¹, Constantina Neophytou², Fotios Mpekris²

¹Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia 2109, Cyprus.

|September 13, 2025

概括

超越T细胞的工程免疫细胞,如NK细胞和巨细胞,通过克服抗原异质性和瘤微环境等挑战,显示出对固体瘤免疫疗法的希望. 这些下一代CAR疗法旨在在固体瘤中获得持久的反应.

科学领域:

免疫治疗是一种免疫疗法.
细胞疗法细胞疗法
固体瘤瘤学固体瘤瘤学

背景情况:

化学抗原受体 (CAR) T细胞疗法对血液癌症有效,但在固体瘤中面临局限性.
挑战包括抗原异质性,免疫抑制瘤微环境和细胞持久性差.
正在探索各种免疫细胞类型作为替代CAR平台.

研究的目的:

审查目前的工程状态,用于固体瘤治疗的各种免疫细胞.
突出不同CAR细胞治疗方法的安全考虑因素.
确定有前途的平台,以解决固体瘤中未得到满足的临床需求.

主要方法:

探索其他CAR平台,包括γδ T细胞,NK细胞,巨细胞和树突细胞.
利用药理学策略,合成生物学和人工智能的进步来设计CAR.
对自主,异种和体内CAR细胞治疗的安全性概况的审查.

主要成果:

汽车NK细胞提供先天的细胞毒性和安全性.
卡尔巨细胞表现出组织透和微环境调节.
CAR γδ T 细胞提供MHC独立的识别.
技术的进步促进了CAR的设计和制造.

结论:

多种CAR免疫细胞平台具有克服固体瘤治疗障碍的潜力.
对CAR细胞类型的战略选择和新技术的整合至关重要.
下一代CAR策略正在开发中,以在固体瘤中获得持久的免疫疗法反应.

关键词:

在CAR NK细胞中,它们是CAR树突细胞.有关CAR的巨细胞.癌症癌症癌症癌症癌症细胞治疗疗法细胞治疗疗法嵌合式抗原受体 (CAR) 是一种免疫疗法免疫疗法

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...